2016 ADX
2016 ADX Banner

Cambridge Healthtech Institute’s Third Annual
Clinical Application of Cell-Free DNA
August 24-25, 2016 | Grand Hyatt Washington | Washington, DC

The quest for validation of circulating cell-free DNA for monitoring treatment response, managing drug resistance and enabling early diagnosis has led to the rapid rise of this industry and importance in the medical community. The use of circulating cell-free DNA to replace tissue biopsy in solid cancers is controversial, but it is clear that it will be an essential tool for monitoring disease in blood borne cancers. The field of maternal and fetal medicine has been greatly advanced by the use of circulating fetal DNA, and will provide lessons for the oncology field for clinical and analytical validation and facing regulatory hurdles.

The meeting will cover a range of topics including:

  • Standardizing collection of material and interpretation of results
  • Profiling cfDNA and circulating RNA, including sequencing, digital PCR and mutation detection
  • Analysis of cfDNA to monitor patients in targeted therapies and manage drug resistance
  • Review of techniques to correlate cfDNA with tumor burden
  • Use of platelet RNA and DNA methylation as a cancer diagnostic
  • Reviewing results of large, multi-center clinical trials in the US and Europe
  • Tracking cancer progression in real time
  • Isolating circulating nucleic acids from urine, blood, cerebrospinal fluid and saliva
  • Comparison of technologies including microarrays and NGS
  • Applications in oncology, transplant medicine, CNS and cardiovascular disease

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality conference program.

If you are interested in presenting, please click here. Replies to proposals can take up to 8-12 weeks. We will notify you once the agenda has been finalized.

Deadline for submission is February 5, 2016.

We welcome your comments, suggestions and speaker suggestions as we shape the 2016 program.

Sincerely,

Christina Lingham

Christina Lingham

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: (+1) 781-972-5464
E: clingham@healthtech.com

For exhibit & sponsorship opportunities, please contact:
Joseph Vacca, M.Sc.
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: jvacca@healthtech.com


2015 Brochure

2015-Next-Generation-Diagnostics-Summit-Brochure-Thumb


Premier Sponsor 

Precision for Medicine 

View All Sponsors

View Media Partners

Media Gallery Thumb

Related Products

Fourth International Molecular Diagnostics Europe
 
MDX_Logo_150x150